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In 1977 it was first shown that light in 
the near-infrared region of the spectrum 
penetrates biological materials sufficiently 
to measure changes in cerebral oxygenation, 
a completely non-invasive technique.1 Since 
then, near-infrared spectroscopy (NIRS) 
has been used to monitor oxyhaemoglobin, 
deoxyhaemoglobin, blood volume and 
cytochrome oxidase for a variety of clinical 
and research applications.
imaging with near-infrared light
oxyhaemoglobin and deoxyhaemoglobin 
absorb light in the 650 - 1 000 nm wavelength 
range, and attenuate measurements of 
light transmitted through tissue. In a non-
scattering medium, the concentration of 
an absorbing compound is proportional 
to the ratio of light attenuation through 
the medium, and the distance between the 
source and the detector. In the case of two 
absorbing compounds, the concentrations of 
each can be calculated from measurements of 
light attenuation at two different wavelengths 
using the Beer Lambert law – the same 
principle used in pulse oximetry. 
However, because biological tissue is highly 
scattering, an unknown amount of light 
attenuation results from scatter rather than 
absorption. Because of this, continuous wave 
NIRS – the simplest and most commonly 
used technique – is able to provide quantified 
concentration changes relative to an arbitrary 
baseline, but not absolute haemoglobin 
concentrations.
Clinically and in neuroscience research, 
NIRS measurements from a single source 
and detector are commonly used. An 
emerging imaging technique, which is 
an area of current research in physics 
and engineering, is diffuse optical 
tomography (DoT), which requires surface 
measurements from multiple overlapping 
source-detector pairs. Three-dimensional 
tomographic images of the interior of a 
small area can then be reconstructed using 
mathematical models of light propagation 
through tissue. 
Applications of niRs
The principal clinical application of NIRS is 
for monitoring brain oxygenation in neonatal 
intensive care.2 Attempts have also been 
made to monitor fetal cerebral oxygenation, 
both transabdominally and during delivery.3 
other pregnancy-related applications include 
transabdominal measurement of placental 
oxygenation4 and assessment of embryo 
viability for in vitro fertilisation.5 NIRS and 
DoT are also used, often in conjunction 
with mammography or ultrasound, to 
detect changes in haemodynamics related to 
tumours in the breast.2   
Perhaps the fastest-growing application area 
is in the study of brain function, where, 
as an alternative to functional magnetic 
resonance imaging (fMRI), NIRS is used to 
measure changes in cerebral oxygenation in 
response to a stimulus. A localised increase 
in metabolic demand in a cortical region 
results in an increase in oxyhaemoglobin 
and a decrease in deoxyhaemoglobin which 
can be measured by detectors placed on the 
scalp, as shown in Fig. 1.
In sports science research, NIRS can be 
used to measure oxygenation in the brain 
and muscles simultaneously, for example to 
investigate the relationship between the two 
and perceived exertion during an exhaustive 
cycling test.6 
NIRS has several advantages which makes it 
useful in clinical and research settings. It is 
portable, allows for long-term monitoring, 
and is relatively inexpensive.7 Although NIRS 
has lower spatial sensitivity than fMRI and 
positron emission tomography (PET), and 
is limited to detecting cortical activation8 
Fig. 1. Set-up of sources and detectors over the 
prefrontal cortex area.
Fig. 2. Increased activation in the right PFC in response to fearful faces in pregnant women at 
trimester 2 compared with non-pregnant controls.
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it does not expose subjects to harmful 
radiation,9 which makes it safe for use in 
studies of infants and pregnant women. 
niRs in cognitive-affective 
neuroscience of pregnancy
Recently, NIRS has been used to 
investigate the regulation of emotion in 
pregnancy.10 This is important as there is 
a high prevalence of mood and anxiety 
disorders in pregnancy, but it is not clear 
why pregnant women are at increased risk 
for developing these disorders. Pregnant 
women underwent an imaging session 
with NIRS to investigate prefrontal cortex 
(PFC) activation in response to emotional 
facial stimuli including fear, and completed 
self-report questionnaires on distress and 
anxiety at each trimester. Non-pregnant 
controls completed these assessments at a 
once-off session. There was significant PFC 
activation in response to fearful faces in both 
pregnant women and controls, compared 
with a resting phase. However, women in 
the second trimester of pregnancy showed 
greater right PFC activation than controls in 
response to fearful faces (Fig. 2). In pregnant 
women, this increased PFC activation was 
significantly associated with increased 
distress and anxiety at all trimesters. This 
suggests that PFC processing of threat 
stimuli is altered in pregnancy, which may 
help explain why pregnant women have an 
increased vulnerability for developing mood 
and anxiety problems. 
Conclusion
Because of its biochemical specificity 
and non-invasiveness NIRS has a wide 
variety of applications. Although it lacks 
the spatial resolution of fMRI and cannot 
detect activation in subcortical structures, 
in neuroscience research NIRS and DoT 
can be used in situations where for ethical 
or practical reasons fMRI can not. NIRS 
therefore holds particular promise for 
investigating cortical brain activity in 
pregnant women and infants, as well as in 
ambulatory tasks which cannot be performed 
inside an MRI scanner. Advances in imaging 
and analysis methods and fusion with other 
imaging modalities will increase the accuracy 
of spatial localisation and provide further 
information about the metabolic dynamics 
of the brain, as well as of other organs.
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Despite the popularity of three-dimensional 
imaging techniques such as computed 
tomography (CT) and magnetic resonance 
imaging (MRI) and a strong likelihood that 
these modalities will soon replace many 
current diagnostic and screening techniques, 
the chest radiograph remains the most 
common radiological procedure, accounting 
for at least one-third of all radiological 
examinations.1 It is simple and inexpensive, 
and has tremendous clinical value.2 However, 
chest radiographs are extremely difficult 
to interpret.1 Poor contrast and complex 
backgrounds comprising superimposed 
anatomical structures (such as large blood 
vessels and ribs) overlapping with regions of 
interest make the detection of abnormalities 
difficult, even for experienced radiologists.3 
The development of computerised systems 
to aid radiologists in reading images and to 
harness the clinical value of chest radiographs 
would ease these difficulties. It is therefore 
not surprising that computer-aided diagnosis 
(CAD) of lung diseases in chest radiographs 
has become a popular area of research in 
medical imaging and diagnostic radiology.4 
Arguably the primary objective of developing 
the digital computer was to create a system 
that could aid or replace humans in 
performing tasks that traditionally relied 
entirely on human intelligence. Soon after 
the development of the first digital computer 
in the 1940s, research began on the topic 
of computerised analysis of radiographic 
images.1 Early studies investigating the 
computerised detection of lung abnormalities 
in chest radiographs, published in the 
1970s, generally assumed that computers 
would ultimately replace radiologists in the 
diagnostic procedure.4 
A distinction should be made between fully 
automated computer diagnosis (FACD) and 
CAD. Although FACD and CAD, in the 
context of radiography, are both based on 
the development of computer algorithms for 
the quantitative analysis of digital images, 
the difference lies in the utilisation of the 
output of the algorithms. An FACD system 
involves no external input; rather, the digital 
radiograph is independently examined by 
the algorithm and the computer’s output 
is the final diagnosis. The accuracy of the 
system is based entirely on the performance 
and accuracy of the algorithm. The output 
of the algorithm used in a CAD system, on 
the other hand, is merely a tool to assist the 
radiologist. It is used as a second opinion and 
the radiologist makes the final diagnosis. The 
performance of the system is measured by 
evaluating the accuracy of the radiologist’s 
diagnosis when using the computer output 
as an aid. The accuracy of the algorithm 
therefore does not have to be as high as it 
does in an FACD system.4
As with the early enthusiasm surrounding 
the capabilities of artificial intelligence, the 
expectations of computerised detection 
schemes for lung diseases have diminished.1 
The primary focus of current research is 
directed at developing CAD systems to aid 
radiologists in making improved diagnoses 
of chest abnormalities. The purpose of these 
systems is to improve the diagnostic accuracy 
and image reading time of radiologists.3 
The literature reveals that the most widely 
researched CAD applications for chest 
abnormalities are:3 detection of nodules, 
detection of interstitial diseases, differential 
diagnosis, evaluation of interval changes, 
and detection of asymmetrical opacities.
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The texture of a region in an image is 
a statistical description of the intensity 
variation in the region, and may provide 
information on the health anatomy 
represented in the image. Although much 
research has been conducted into the use 
of computer-aided textural analysis for the 
detection of interstitial lung diseases in chest 
radiographs, research into its application for 
the detection of pulmonary tuberculosis (TB) 
is limited. Perhaps the most comprehensive 
work on the computer-aided detection of TB 
has been presented by van Ginneken et al.5 
In this work, the lung fields were subdivided 
into regions of interest, which were classified 
as normal or abnormal based on the analysis 
of textural features. 
The chest radiograph is often the main 
diagnostic tool for childhood TB in endemic 
settings.6 We have used the methods of van 
Ginneken et al.5 to classify lung regions in 
paediatric chest X-ray images and produce a 
probability map indicating the likelihood of 
abnormality in any region towards CAD of 
childhood TB.7 Fig. 1 shows examples of the 
successful classification of abnormal regions in 
images obtained using a linear-slot-scanning 
digital X-ray machine (Lodox Statscan). 
Preliminary work on CAD for TB detection 
shows promise, and motivates further 
development of computerised TB detection 
schemes. 
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Fig. 1. Original images (left) and probability maps (right). The first pair shows a healthy chest scan 
and the second pair shows a chest scan with small regions of abnormality. In each case the prob-
ability map indicates the abnormality in the appropriate region (brighter intensities = more abnor-
mal), and accurately depicts the rest of the lung fields as normal (darker intensities). Outlines of 
abnormal regions, made by a radiologist, and lung borders are shown. 
SINGLE SUTURE
Stay of execution
Delays in the execution of death-row inmates are likely to lengthen now that the uSA’s sole manufacturer of a lethal injection drug has announced 
that it is abandoning production.
Hospira had already stopped making the anaesthetic, sodium thiopental, in the uSA late last year because of difficulties in obtaining the raw 
materials. It intended to resume production in Italy, but recently bowed to pressure from Italian authorities who do not want a drug exported 
from their country to be used in capital punishment.
Hospira said that it would not take the risk that it might be held liable if its Italian-made sodium thiopental was used as a tool for execution. It 
claims that it has never condoned this use of the drug.
Last year’s halt in uS production has already delayed executions in California and oklahoma. Some states managed to acquire the drug from 
the uK, but last November the British government banned its export for use in capital punishment.
New Scientist, 29 January 2011, p. 5.
